King's College London, Department of Nutritional Sciences, London, United Kingdom.
Queen Mary University of London, Wingate Institute, London, United Kingdom.
Nutrition. 2019 May;61:157-163. doi: 10.1016/j.nut.2018.11.013. Epub 2018 Nov 23.
This study aimed to assess the use and perceived effectiveness of probiotics by the general population (with or without self-reported constipation), and their recommendation and perceived effectiveness by general practitioners (GPs) and gastroenterology specialists.
A cross-sectional, primarily online, survey was undertaken. Responses were compared between groups using χ tests, and logistic regression was employed to identify predictors of probiotic use.
A total of 2557 members of the general population (1623 self-reported constipation, 934 without), 411 GPs, and 365 gastroenterology specialists completed the survey. A total of 37% of the general population with self-reported constipation had tried probiotics, compared with 11% of those without (P < 0.001), with the strongest predictors of use being the belief that probiotics have been tested in appropriate studies (odds ratio [OR] 1.9; P < 0.001), receiving a formal constipation diagnosis by a doctor (OR 1.6; P < 0.001), and a self-diagnosis of constipation (OR 1.6; P < 0.001). Only 26% of GPs and 34% of gastroenterology specialists recommended probiotics for constipation (P = 0.012). Almost two-thirds of the general population (65%) believed that probiotics had been tested in studies for constipation, whereas only 35% GPs and 43% gastroenterology specialists believed this (P < 0.001).
There is high usage and perceived evidence for probiotics among people with constipation. However, most GPs and gastroenterology specialists do not recommend them for constipation, suggesting a need for further research and education of health care professionals on existing evidence.
本研究旨在评估普通人群(无论是否自述患有便秘)对益生菌的使用情况和认知有效性,以及全科医生和胃肠病专家对益生菌的推荐情况和认知有效性。
采用横断面、主要在线调查的方式进行。使用卡方检验比较各组间的差异,采用逻辑回归分析确定益生菌使用的预测因素。
共有 2557 名普通人群(1623 名自述便秘,934 名无便秘)、411 名全科医生和 365 名胃肠病专家完成了调查。自述患有便秘的普通人群中,有 37%的人尝试过益生菌,而无便秘的人群中只有 11%的人尝试过(P<0.001),使用益生菌的最强预测因素是认为益生菌已经在适当的研究中进行了测试(比值比[OR] 1.9;P<0.001)、曾被医生正式诊断为便秘(OR 1.6;P<0.001)和自我诊断为便秘(OR 1.6;P<0.001)。只有 26%的全科医生和 34%的胃肠病专家推荐益生菌治疗便秘(P=0.012)。近三分之二的普通人群(65%)认为益生菌已经在针对便秘的研究中进行了测试,而只有 35%的全科医生和 43%的胃肠病专家认为如此(P<0.001)。
便秘患者对益生菌的使用和认知有效性很高。然而,大多数全科医生和胃肠病专家不推荐将其用于治疗便秘,这表明需要进一步研究并对卫生保健专业人员进行现有证据的教育。